These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
196 related articles for article (PubMed ID: 34781870)
41. Modulation of human T-type calcium channels by synthetic cannabinoid receptor agonists in vitro. Bladen C; Mirlohi S; Santiago M; Longworth M; Kassiou M; Banister S; Connor M Neuropharmacology; 2021 Apr; 187():108478. PubMed ID: 33600843 [TBL] [Abstract][Full Text] [Related]
43. Synthetic cannabinoid receptor agonists profile in infused papers seized in Brazilian prisons. Rodrigues TB; Souza MP; de Melo Barbosa L; de Carvalho Ponce J; Júnior LFN; Yonamine M; Costa JL Forensic Toxicol; 2022 Jan; 40(1):119-124. PubMed ID: 36454481 [TBL] [Abstract][Full Text] [Related]
44. The impact of Australian legislative changes on synthetic cannabinoid exposures reported to the New South Wales Poisons Information Centre. Cairns R; Brown JA; Gunja N; Buckley NA Int J Drug Policy; 2017 May; 43():74-82. PubMed ID: 28343112 [TBL] [Abstract][Full Text] [Related]
45. Characteristics of novel psychoactive substance exposures reported to New York City Poison Center, 2011-2014. Palamar JJ; Su MK; Hoffman RS Am J Drug Alcohol Abuse; 2016; 42(1):39-47. PubMed ID: 26678258 [TBL] [Abstract][Full Text] [Related]
46. 'Synthetic cannabis': A dangerous misnomer. Darke S; Banister S; Farrell M; Duflou J; Lappin J Int J Drug Policy; 2021 Dec; 98():103396. PubMed ID: 34343944 [TBL] [Abstract][Full Text] [Related]
47. Characterizing Trends in Synthetic Cannabinoid Receptor Agonist Use from Patient Clinical Evaluations during Medical Toxicology Consultation. Tebo C; Mazer-Amirshahi M; Wax P; Campleman S; Boyer E; Brent J; Sheth A; Daniuaityte R; Carlson R J Psychoactive Drugs; 2021; 53(3):207-214. PubMed ID: 33225872 [TBL] [Abstract][Full Text] [Related]
48. AB-CHMINACA, AB-PINACA, and FUBIMINA: Affinity and Potency of Novel Synthetic Cannabinoids in Producing Δ9-Tetrahydrocannabinol-Like Effects in Mice. Wiley JL; Marusich JA; Lefever TW; Antonazzo KR; Wallgren MT; Cortes RA; Patel PR; Grabenauer M; Moore KN; Thomas BF J Pharmacol Exp Ther; 2015 Sep; 354(3):328-39. PubMed ID: 26105953 [TBL] [Abstract][Full Text] [Related]
49. Synthesis and pharmacology of new psychoactive substance 5F-CUMYL-P7AICA, a scaffold- hopping analog of synthetic cannabinoid receptor agonists 5F-CUMYL-PICA and 5F-CUMYL-PINACA. Banister SD; Adams A; Kevin RC; Macdonald C; Glass M; Boyd R; Connor M; McGregor IS; Havel CM; Bright SJ; Vilamala MV; Lladanosa CG; Barratt MJ; Gerona RR Drug Test Anal; 2019 Feb; 11(2):279-291. PubMed ID: 30151911 [TBL] [Abstract][Full Text] [Related]
50. Synthetic Cannabinoid Receptor Agonists Detection Using Fluorescence Spectral Fingerprinting. May B; Naqi HA; Tipping M; Scott J; Husbands SM; Blagbrough IS; Pudney CR Anal Chem; 2019 Oct; 91(20):12971-12979. PubMed ID: 31580647 [TBL] [Abstract][Full Text] [Related]
51. Shape matters: The application of activity-based in vitro bioassays and chiral profiling to the pharmacological evaluation of synthetic cannabinoid receptor agonists in drug-infused papers seized in prisons. Antonides LH; Cannaert A; Norman C; NicDáeid N; Sutcliffe OB; Stove CP; McKenzie C Drug Test Anal; 2021 Mar; 13(3):628-643. PubMed ID: 33161649 [TBL] [Abstract][Full Text] [Related]
52. Systematic evaluation of a panel of 30 synthetic cannabinoid receptor agonists structurally related to MMB-4en-PICA, MDMB-4en-PINACA, ADB-4en-PINACA, and MMB-4CN-BUTINACA using a combination of binding and different CB Pike E; Grafinger KE; Cannaert A; Ametovski A; Luo JL; Sparkes E; Cairns EA; Ellison R; Gerona R; Stove CP; Auwärter V; Banister SD Drug Test Anal; 2021 Jul; 13(7):1383-1401. PubMed ID: 33787091 [TBL] [Abstract][Full Text] [Related]
53. Finding order in chemical chaos - Continuing characterization of synthetic cannabinoid receptor agonists. Marusich JA; Wiley JL; Lefever TW; Patel PR; Thomas BF Neuropharmacology; 2018 May; 134(Pt A):73-81. PubMed ID: 29113898 [TBL] [Abstract][Full Text] [Related]
54. Comprehensive Characterization of a Systematic Library of Alkyl and Alicyclic Synthetic Cannabinoids Related to CUMYL-PICA, CUMYL-BUTICA, CUMYL-CBMICA, and CUMYL-PINACA. Janssens LK; Ametovski A; Sparkes E; Boyd R; Lai F; Maloney CJ; Rhook D; Gerona RR; Connolly M; Liu H; Hibbs DE; Cairns EA; Banister SD; Stove CP ACS Chem Neurosci; 2023 Jan; 14(1):35-52. PubMed ID: 36530139 [TBL] [Abstract][Full Text] [Related]
55. Distinct pharmacology and metabolism of K2 synthetic cannabinoids compared to Δ(9)-THC: mechanism underlying greater toxicity? Fantegrossi WE; Moran JH; Radominska-Pandya A; Prather PL Life Sci; 2014 Feb; 97(1):45-54. PubMed ID: 24084047 [TBL] [Abstract][Full Text] [Related]
56. Synthetic Cannabinoids: Pharmacology, Behavioral Effects, and Abuse Potential. Tai S; Fantegrossi WE Curr Addict Rep; 2014 Jun; 1(2):129-136. PubMed ID: 26413452 [TBL] [Abstract][Full Text] [Related]
57. Synthetic cannabinoids: the hidden side of Spice drugs. Pintori N; Loi B; Mereu M Behav Pharmacol; 2017 Sep; 28(6):409-419. PubMed ID: 28692429 [TBL] [Abstract][Full Text] [Related]
58. In vitro determination of the efficacy of illicit synthetic cannabinoids at CB Sachdev S; Vemuri K; Banister SD; Longworth M; Kassiou M; Santiago M; Makriyannis A; Connor M Br J Pharmacol; 2019 Dec; 176(24):4653-4665. PubMed ID: 31412133 [TBL] [Abstract][Full Text] [Related]